SAN.PA : Summary for SANOFI - Yahoo Finance

U.S. Markets open in 2 hrs 9 mins

Sanofi (SAN.PA)


Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
75.43-0.19 (-0.25%)
As of 1:05PM CET. Market open.
People also watch
FP.PABN.PACS.PAOR.PAAI.PA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close75.62
Open75.42
Bid71.12 x 1000
Ask71.74 x 44000
Day's Range74.54 - 75.43
52 Week Range62.50 - 79.07
Volume460,164
Avg. Volume2,947,052
Market Cap94.7B
Beta0.74
PE Ratio (TTM)23.15
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.35 (4.21%)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire6 hours ago

    Sanofi: Availability of the Pre-quarterly Results Communication

    Availability of the Pre-quarterly Results Communication Paris, France - January 23, 2017 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors" ...

  • Reuters3 days ago

    Pharma CEOs in Davos put brave face on Trump presidency

    Leaders of the global pharmaceutical industry, blasted by incoming U.S. President Donald Trump for "getting away with murder" on drug prices, are putting a brave face on the challenges in their biggest market.

  • Reuters3 days ago

    Sanofi's M&A misses frustrate some investors in drugmaker

    PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker. Olivier Brandicourt's failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors. In an interview at the World Economic Forum in the Swiss resort of Davos this week Brandicourt defended his track record, citing an unwillingness to overpay for pricey assets and a paucity of good opportunities.